The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.
Vaccines, Blood & Biologics
Submission Type: BLA Submission ID: 125363/0 Office: OVRR
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
Telecon Date/Time: 01-Jun-2012 02:40 AM Initiated by FDA? Yes
Author: DAVID STATEN
FDA decision on temp storage for diluent
FDA Participants: None
Non-FDA Participants: None
Trans-BLA Group: No
Related STNs: None
Related PMCs: None
After internal discussion, FDA conveyed to GSK that their “batching” of storage data is acceptable. The storage condition for the PI and labels/carton will read;
"Store refrigerated or at controlled room temperature between 2° and 25°C (36° and 77°F). Do not freeze. Discard if the diluent has been frozen"